ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Personalized Precision Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-13T17153
Home | Market Reports | Health| Pharmacy
Global Personalized Precision Medicine Market Research Report 2024
BUY CHAPTERS

Global Personalized Precision Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13T17153
Report
November 2025
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agilent Technologies
Biogen
Johnson & Johnson
BOAI NKY PHARMACEUTICALS LTD.
Novartis
Pfizer Inc
Roche
Astrazeneca plc
Sanofi
Amgen Inc
Takeda Pharmaceutical
Merck
Eli Lilly
IQVIA
AbbVie
PAREXEL
Johnson & Johnson

Personalized Precision Medicine Market

The global Personalized Precision Medicine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Personalized precision medicine is an important development direction in the medical field. It is expected to provide patients with more effective and safer treatment options and improve medical quality and patient satisfaction.
From a downstream perspective, Tumors and Cancer accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Personalized Precision Medicine leading manufacturers including Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca, Sanofi, Amgen, etc., dominate supply; the top five capture approximately % of global revenue, with Agilent Technologies leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Personalized Precision Medicine market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Personalized Precision Medicine Market Report

Report Metric Details
Report Name Personalized Precision Medicine Market
Segment by Type
  • Gene Therapy
  • Personalized Medication
  • Health Management
  • Others
Segment by Application
  • Tumors and Cancer
  • Cardiovascular Diseases
  • Genetic Disease
  • Autoimmune Disease
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca, Sanofi, Amgen, Takeda Pharmaceutical, Merck, Eli Lilly, IQVIA, AbbVie, Parexel
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Personalized Precision Medicine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Personalized Precision Medicine Market report?

Ans: The main players in the Personalized Precision Medicine Market are Agilent Technologies, Biogen, Johnson & Johnson, Boai NKY Pharmaceuticals Ltd., Novartis, Pfizer, Roche, AstraZeneca, Sanofi, Amgen, Takeda Pharmaceutical, Merck, Eli Lilly, IQVIA, AbbVie, Parexel

What are the Application segmentation covered in the Personalized Precision Medicine Market report?

Ans: The Applications covered in the Personalized Precision Medicine Market report are Tumors and Cancer, Cardiovascular Diseases, Genetic Disease, Autoimmune Disease, Others

What are the Type segmentation covered in the Personalized Precision Medicine Market report?

Ans: The Types covered in the Personalized Precision Medicine Market report are Gene Therapy, Personalized Medication, Health Management, Others

1 Study Coverage
1.1 Introduction to Personalized Precision Medicine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Personalized Precision Medicine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gene Therapy
1.2.3 Personalized Medication
1.2.4 Health Management
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Personalized Precision Medicine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tumors and Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Genetic Disease
1.3.5 Autoimmune Disease
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Personalized Precision Medicine Revenue Estimates and Forecasts 2020-2031
2.2 Global Personalized Precision Medicine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Personalized Precision Medicine Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Personalized Precision Medicine Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Gene Therapy Market Size by Players
3.3.2 Personalized Medication Market Size by Players
3.3.3 Health Management Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Personalized Precision Medicine Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Personalized Precision Medicine Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Personalized Precision Medicine Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Personalized Precision Medicine Market Size by Type (2020-2031)
6.4 North America Personalized Precision Medicine Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Personalized Precision Medicine Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Personalized Precision Medicine Market Size by Type (2020-2031)
7.4 Europe Personalized Precision Medicine Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Personalized Precision Medicine Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Personalized Precision Medicine Market Size by Type (2020-2031)
8.4 Asia-Pacific Personalized Precision Medicine Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Personalized Precision Medicine Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Personalized Precision Medicine Market Size by Type (2020-2031)
9.4 Central and South America Personalized Precision Medicine Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Personalized Precision Medicine Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Personalized Precision Medicine Market Size by Type (2020-2031)
10.4 Middle East and Africa Personalized Precision Medicine Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Personalized Precision Medicine Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Agilent Technologies
11.1.1 Agilent Technologies Corporation Information
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Personalized Precision Medicine Product Features and Attributes
11.1.4 Agilent Technologies Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.1.5 Agilent Technologies Personalized Precision Medicine Revenue by Product in 2024
11.1.6 Agilent Technologies Personalized Precision Medicine Revenue by Application in 2024
11.1.7 Agilent Technologies Personalized Precision Medicine Revenue by Geographic Area in 2024
11.1.8 Agilent Technologies Personalized Precision Medicine SWOT Analysis
11.1.9 Agilent Technologies Recent Developments
11.2 Biogen
11.2.1 Biogen Corporation Information
11.2.2 Biogen Business Overview
11.2.3 Biogen Personalized Precision Medicine Product Features and Attributes
11.2.4 Biogen Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.2.5 Biogen Personalized Precision Medicine Revenue by Product in 2024
11.2.6 Biogen Personalized Precision Medicine Revenue by Application in 2024
11.2.7 Biogen Personalized Precision Medicine Revenue by Geographic Area in 2024
11.2.8 Biogen Personalized Precision Medicine SWOT Analysis
11.2.9 Biogen Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Personalized Precision Medicine Product Features and Attributes
11.3.4 Johnson & Johnson Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.3.5 Johnson & Johnson Personalized Precision Medicine Revenue by Product in 2024
11.3.6 Johnson & Johnson Personalized Precision Medicine Revenue by Application in 2024
11.3.7 Johnson & Johnson Personalized Precision Medicine Revenue by Geographic Area in 2024
11.3.8 Johnson & Johnson Personalized Precision Medicine SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Boai NKY Pharmaceuticals Ltd.
11.4.1 Boai NKY Pharmaceuticals Ltd. Corporation Information
11.4.2 Boai NKY Pharmaceuticals Ltd. Business Overview
11.4.3 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Product Features and Attributes
11.4.4 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.4.5 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue by Product in 2024
11.4.6 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue by Application in 2024
11.4.7 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine Revenue by Geographic Area in 2024
11.4.8 Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine SWOT Analysis
11.4.9 Boai NKY Pharmaceuticals Ltd. Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Business Overview
11.5.3 Novartis Personalized Precision Medicine Product Features and Attributes
11.5.4 Novartis Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.5.5 Novartis Personalized Precision Medicine Revenue by Product in 2024
11.5.6 Novartis Personalized Precision Medicine Revenue by Application in 2024
11.5.7 Novartis Personalized Precision Medicine Revenue by Geographic Area in 2024
11.5.8 Novartis Personalized Precision Medicine SWOT Analysis
11.5.9 Novartis Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Personalized Precision Medicine Product Features and Attributes
11.6.4 Pfizer Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.6.5 Pfizer Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Business Overview
11.7.3 Roche Personalized Precision Medicine Product Features and Attributes
11.7.4 Roche Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.7.5 Roche Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Personalized Precision Medicine Product Features and Attributes
11.8.4 AstraZeneca Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.8.5 AstraZeneca Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Personalized Precision Medicine Product Features and Attributes
11.9.4 Sanofi Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.9.5 Sanofi Recent Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Business Overview
11.10.3 Amgen Personalized Precision Medicine Product Features and Attributes
11.10.4 Amgen Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Takeda Pharmaceutical
11.11.1 Takeda Pharmaceutical Corporation Information
11.11.2 Takeda Pharmaceutical Business Overview
11.11.3 Takeda Pharmaceutical Personalized Precision Medicine Product Features and Attributes
11.11.4 Takeda Pharmaceutical Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.11.5 Takeda Pharmaceutical Recent Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Business Overview
11.12.3 Merck Personalized Precision Medicine Product Features and Attributes
11.12.4 Merck Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.12.5 Merck Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Corporation Information
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Personalized Precision Medicine Product Features and Attributes
11.13.4 Eli Lilly Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.13.5 Eli Lilly Recent Developments
11.14 IQVIA
11.14.1 IQVIA Corporation Information
11.14.2 IQVIA Business Overview
11.14.3 IQVIA Personalized Precision Medicine Product Features and Attributes
11.14.4 IQVIA Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.14.5 IQVIA Recent Developments
11.15 AbbVie
11.15.1 AbbVie Corporation Information
11.15.2 AbbVie Business Overview
11.15.3 AbbVie Personalized Precision Medicine Product Features and Attributes
11.15.4 AbbVie Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.15.5 AbbVie Recent Developments
11.16 Parexel
11.16.1 Parexel Corporation Information
11.16.2 Parexel Business Overview
11.16.3 Parexel Personalized Precision Medicine Product Features and Attributes
11.16.4 Parexel Personalized Precision Medicine Revenue and Gross Margin (2020-2025)
11.16.5 Parexel Recent Developments
12 Personalized Precision MedicineIndustry Chain Analysis
12.1 Personalized Precision Medicine Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Personalized Precision Medicine Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Personalized Precision Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Agilent Technologies
Biogen
Johnson & Johnson
BOAI NKY PHARMACEUTICALS LTD.
Novartis
Pfizer Inc
Roche
Astrazeneca plc
Sanofi
Amgen Inc
Takeda Pharmaceutical
Merck
Eli Lilly
IQVIA
AbbVie
PAREXEL
Johnson & Johnson
List of Tables
 Table 1. Global Personalized Precision Medicine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Personalized Precision Medicine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Personalized Precision Medicine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Personalized Precision Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Personalized Precision Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Personalized Precision Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Personalized Precision Medicine Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Personalized Precision Medicine by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Precision Medicine as of 2024)
 Table 11. Global Personalized Precision Medicine Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Personalized Precision Medicine Companies Headquarters
 Table 13. Global Personalized Precision Medicine Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Personalized Precision Medicine Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Personalized Precision Medicine Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Personalized Precision Medicine Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Personalized Precision Medicine Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Personalized Precision Medicine High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Personalized Precision Medicine Growth Accelerators and Market Barriers
 Table 25. North America Personalized Precision Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Personalized Precision Medicine Growth Accelerators and Market Barriers
 Table 27. Europe Personalized Precision Medicine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Personalized Precision Medicine Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Personalized Precision Medicine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Personalized Precision Medicine Investment Opportunities and Key Challenges
 Table 31. Central and South America Personalized Precision Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Personalized Precision Medicine Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Personalized Precision Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Agilent Technologies Corporation Information
 Table 35. Agilent Technologies Description and Major Businesses
 Table 36. Agilent Technologies Product Features and Attributes
 Table 37. Agilent Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Agilent Technologies Revenue Proportion by Product in 2024
 Table 39. Agilent Technologies Revenue Proportion by Application in 2024
 Table 40. Agilent Technologies Revenue Proportion by Geographic Area in 2024
 Table 41. Agilent Technologies Personalized Precision Medicine SWOT Analysis
 Table 42. Agilent Technologies Recent Developments
 Table 43. Biogen Corporation Information
 Table 44. Biogen Description and Major Businesses
 Table 45. Biogen Product Features and Attributes
 Table 46. Biogen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Biogen Revenue Proportion by Product in 2024
 Table 48. Biogen Revenue Proportion by Application in 2024
 Table 49. Biogen Revenue Proportion by Geographic Area in 2024
 Table 50. Biogen Personalized Precision Medicine SWOT Analysis
 Table 51. Biogen Recent Developments
 Table 52. Johnson & Johnson Corporation Information
 Table 53. Johnson & Johnson Description and Major Businesses
 Table 54. Johnson & Johnson Product Features and Attributes
 Table 55. Johnson & Johnson Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Johnson & Johnson Revenue Proportion by Product in 2024
 Table 57. Johnson & Johnson Revenue Proportion by Application in 2024
 Table 58. Johnson & Johnson Revenue Proportion by Geographic Area in 2024
 Table 59. Johnson & Johnson Personalized Precision Medicine SWOT Analysis
 Table 60. Johnson & Johnson Recent Developments
 Table 61. Boai NKY Pharmaceuticals Ltd. Corporation Information
 Table 62. Boai NKY Pharmaceuticals Ltd. Description and Major Businesses
 Table 63. Boai NKY Pharmaceuticals Ltd. Product Features and Attributes
 Table 64. Boai NKY Pharmaceuticals Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Boai NKY Pharmaceuticals Ltd. Revenue Proportion by Product in 2024
 Table 66. Boai NKY Pharmaceuticals Ltd. Revenue Proportion by Application in 2024
 Table 67. Boai NKY Pharmaceuticals Ltd. Revenue Proportion by Geographic Area in 2024
 Table 68. Boai NKY Pharmaceuticals Ltd. Personalized Precision Medicine SWOT Analysis
 Table 69. Boai NKY Pharmaceuticals Ltd. Recent Developments
 Table 70. Novartis Corporation Information
 Table 71. Novartis Description and Major Businesses
 Table 72. Novartis Product Features and Attributes
 Table 73. Novartis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Novartis Revenue Proportion by Product in 2024
 Table 75. Novartis Revenue Proportion by Application in 2024
 Table 76. Novartis Revenue Proportion by Geographic Area in 2024
 Table 77. Novartis Personalized Precision Medicine SWOT Analysis
 Table 78. Novartis Recent Developments
 Table 79. Pfizer Corporation Information
 Table 80. Pfizer Description and Major Businesses
 Table 81. Pfizer Product Features and Attributes
 Table 82. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Pfizer Recent Developments
 Table 84. Roche Corporation Information
 Table 85. Roche Description and Major Businesses
 Table 86. Roche Product Features and Attributes
 Table 87. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Roche Recent Developments
 Table 89. AstraZeneca Corporation Information
 Table 90. AstraZeneca Description and Major Businesses
 Table 91. AstraZeneca Product Features and Attributes
 Table 92. AstraZeneca Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Recent Developments
 Table 94. Sanofi Corporation Information
 Table 95. Sanofi Description and Major Businesses
 Table 96. Sanofi Product Features and Attributes
 Table 97. Sanofi Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Sanofi Recent Developments
 Table 99. Amgen Corporation Information
 Table 100. Amgen Description and Major Businesses
 Table 101. Amgen Product Features and Attributes
 Table 102. Amgen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Amgen Recent Developments
 Table 104. Takeda Pharmaceutical Corporation Information
 Table 105. Takeda Pharmaceutical Description and Major Businesses
 Table 106. Takeda Pharmaceutical Product Features and Attributes
 Table 107. Takeda Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Takeda Pharmaceutical Recent Developments
 Table 109. Merck Corporation Information
 Table 110. Merck Description and Major Businesses
 Table 111. Merck Product Features and Attributes
 Table 112. Merck Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Merck Recent Developments
 Table 114. Eli Lilly Corporation Information
 Table 115. Eli Lilly Description and Major Businesses
 Table 116. Eli Lilly Product Features and Attributes
 Table 117. Eli Lilly Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Eli Lilly Recent Developments
 Table 119. IQVIA Corporation Information
 Table 120. IQVIA Description and Major Businesses
 Table 121. IQVIA Product Features and Attributes
 Table 122. IQVIA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. IQVIA Recent Developments
 Table 124. AbbVie Corporation Information
 Table 125. AbbVie Description and Major Businesses
 Table 126. AbbVie Product Features and Attributes
 Table 127. AbbVie Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. AbbVie Recent Developments
 Table 129. Parexel Corporation Information
 Table 130. Parexel Description and Major Businesses
 Table 131. Parexel Product Features and Attributes
 Table 132. Parexel Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Parexel Recent Developments
 Table 134. Raw Materials Key Suppliers
 Table 135. Distributors List
 Table 136. Market Trends and Market Evolution
 Table 137. Market Drivers and Opportunities
 Table 138. Market Challenges, Risks, and Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources


List of Figures
 Figure 1. Personalized Precision Medicine Product Picture
 Figure 2. Global Personalized Precision Medicine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Gene Therapy Product Picture
 Figure 4. Personalized Medication Product Picture
 Figure 5. Health Management Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Personalized Precision Medicine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Tumors and Cancer
 Figure 9. Cardiovascular Diseases
 Figure 10. Genetic Disease
 Figure 11. Autoimmune Disease
 Figure 12. Others
 Figure 13. Personalized Precision Medicine Report Years Considered
 Figure 14. Global Personalized Precision Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Personalized Precision Medicine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Personalized Precision Medicine Revenue Market Share by Region (2020-2031)
 Figure 18. Global Personalized Precision Medicine Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Gene Therapy Revenue Market Share by Player in 2024
 Figure 21. Personalized Medication Revenue Market Share by Player in 2024
 Figure 22. Health Management Revenue Market Share by Player in 2024
 Figure 23. Others Revenue Market Share by Player in 2024
 Figure 24. Global Personalized Precision Medicine Revenue Market Share by Type (2020-2031)
 Figure 25. Global Personalized Precision Medicine Revenue Market Share by Application (2020-2031)
 Figure 26. North America Personalized Precision Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Personalized Precision Medicine Revenue (US$ Million) in 2024
 Figure 28. North America Personalized Precision Medicine Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Personalized Precision Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Personalized Precision Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Personalized Precision Medicine Revenue (US$ Million) in 2024
 Figure 35. Europe Personalized Precision Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Personalized Precision Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 38. France Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Personalized Precision Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Personalized Precision Medicine Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Personalized Precision Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Personalized Precision Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 50. India Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Personalized Precision Medicine Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Personalized Precision Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Personalized Precision Medicine Revenue (US$ Million) in 2024
 Figure 58. Central and South America Personalized Precision Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Personalized Precision Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Personalized Precision Medicine Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Personalized Precision Medicine Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Personalized Precision Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Personalized Precision Medicine Revenue (US$ Million) in 2024
 Figure 64. South America Personalized Precision Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Personalized Precision Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Personalized Precision Medicine Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Personalized Precision Medicine Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Personalized Precision Medicine Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Personalized Precision Medicine Revenue (2020-2025) & (US$ Million)
 Figure 70. Personalized Precision Medicine Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Precision Medicine Diagnostics Market
Global Precision Cancer Medicine Market Research Report 2024
Global Precision Medicine Research and Development Platform Market Research Report 2024
Global Personalized Cancer Medicine Market Research Report 2025
Global Precision Psychiatry Market Research Report 2024
Global Data Driven Precision Medical Service Market Research Report 2024
Global Personalized Cell Therapy Market Research Report 2024
Global Personalized Medical Service for Families Market Research Report 2024
Artificial Intelligence AI in Precision Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Personalized Medicines In Oncology Market Research Report 2024
Global Non Oncology Precision Medicine Market Research Report 2024
Personalized Medical Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Precision Nutrition Market Research Report 2024
Personalized Medicine PM Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Smart Precision Medicine Software Market Insights Forecast to 2030
Global Precision Cancer Tests Market Research Report 2024
Oncology Precision Medicine Market
Global Customized Genetic Testing Market Research Report 2025
Global Precision Medical Components Market Research Report 2024
Genomic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions